p-tau217: What the new Alzheimer’s blood test can — and can’t — do

Diagnosing Alzheimer's disease has traditionally involved a combination of cognitive assessments, brain scans, and, in some cases, invasive spinal fluid tests—an often lengthy process that can delay clarity for people experiencing memory loss and cognitive decline. Now, a simple blood test measuring a protein called p-tau217 is offering fresh hope. Backed by a recent JAMA study and additional findings presented at the Alzheimer's Association International Conference (AAIC), researchers say the test could help doctors identify Alzheimer's disease earlier and distinguish it from other causes of dementia. While doctors caution that it is not a replacement for conventional diagnostic methods, they believe it could become a valuable addition to the diagnostic toolkit, making Alzheimer's detection faster, less invasive, and more accessible. DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.